EdgeMarketInstruments › XNCR

XNCR — Xencor Inc

US Healthcare Pharma & biotech equity mkt cap 2.0B
27.80 +2.96% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 7.44 · high 27.80

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+2.96%
1 week+19.11%
1 month+42.35%
3 months+146.67%
6 months+143.65%
Year to date+86.33%
1 year+270.17%
3 years+23.17%
5 years-13.77%

Technicals

RSI 1490.3
vs 50-day avg+53.12%
vs 200-day avg+92.07%
Volatility 1y67.2%
Max drawdown 1y-42.61%
Avg volume 30d1.2M
Daily bars held2,674
History from2016-01-04

Measured signals that fired on XNCR

datesignal measured base rate
2026-08-19Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-08-10Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-08-06Equal highs taken out
structure
-0.70% over 21 days · t = -8.28 · n = 68,636
statistically distinguishable from its control group
2026-07-20Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-07-20Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-05-15Bollinger bandwidth breaks out of its own compression
structure
-0.63% over 21 days · t = -2.80 · n = 7,196
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-18Feigal Ellen
Director
Open-market sale 10b5-1 plan6.8K13.0689.4K
2026-06-16GORMAN KEVIN CHARLES
Director
Grant or award10.3K0.000
2026-06-16SIMPSON TODD E
Director
Grant or award10.3K0.000
2026-06-16Feigal Ellen
Director
Grant or award10.3K0.000
2026-06-16Montgomery Alan Bruce
Director
Grant or award10.3K0.000
2026-06-16RANIERI RICHARD J
Director
Grant or award10.3K0.000
2026-06-16GUSTAFSON KURT A
Director
Grant or award10.3K0.000
2026-06-16Deshaies Raymond Joseph
Director
Grant or award10.3K0.000
2026-06-16Klencke Barbara
Director
Grant or award10.3K0.000
2026-06-15GORMAN KEVIN CHARLES
Director
Open-market sale 10b5-1 plan7.5K12.3192.7K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
BlackRock, Inc.157.2M13.0M
PRIMECAP MANAGEMENT CO/CA/124.7M10.3M
BVF INC/IL86.0M7.1M
RTW INVESTMENTS, LP81.7M6.8M
RA CAPITAL MANAGEMENT, L.P.59.1M4.9M
STATE STREET CORP52.5M4.4M
VANGUARD PORTFOLIO MANAGEMENT LLC42.2M3.5M
VANGUARD CAPITAL MANAGEMENT LLC37.4M3.1M
TCG Crossover Management, LLC29.6M2.5M
EcoR1 Capital, LLC26.3M2.2M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d65.4% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about XNCR

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open XNCR in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →